ProfileGDS5678 / 1441298_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 21% 22% 22% 21% 21% 22% 21% 21% 21% 21% 21% 21% 21% 21% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.5305821
GSM967853U87-EV human glioblastoma xenograft - Control 22.507522
GSM967854U87-EV human glioblastoma xenograft - Control 32.5094422
GSM967855U87-EV human glioblastoma xenograft - Control 42.4547121
GSM967856U87-EV human glioblastoma xenograft - Control 52.4502621
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5732622
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.5263121
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4847921
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4729621
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4949921
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.4914121
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4775821
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.5006921
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4954221